CanSense
Edit

CanSense

https://cansenseltd.com/
Last activity: 09.01.2024
Categories: DataBioTechArtificial IntelligenceAnalyticsResearchLearnDiagnostics
CanSense is a company that specializes in cancer diagnostics. They offer a simple blood test that can detect bowel cancer early. The test is non-invasive and reduces colonoscopies. Bowel (colorectal) cancer is the second most common cancer globally. However, they are a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
Followers
613
Mentions
4
Persons
5
Location: United Kingdom, England, Wales
Employees: 1-10
Total raised: $1.78M
Founded date: 2018
Founders name: Cerys Jenkins
Founders Related Locations: United Kingdom; United Kingdom, Scotland, Glasgow

Funding Rounds 1

DateSeriesAmountInvestors
08.03.2023Seed$1.78MMercia Ass...

Persons 5

DateFirst NameLast NameTitleLinkedInLocation
-AdamBryantChief Exec...linkedin.c...-
-PeterDunstan-linkedin.c...-
-DeanWebster-linkedin.c...-
-JustinJohn-linkedin.c...-
-CerysJenkinsCo-Founder...linkedin.c...-

Mentions in press and media 4

DateTitleDescriptionSource
09.01.2024GP finger-prick blood test could transform bowel cancer diag...Welsh patients are playing a major role in the way that bowel cancer is diagnosed, thanks to a leadi...einpresswi...
09.03.2023Start-up raises £1.5m for blood test to detect early-stage b...CanSense – a Swansea company which has developed a blood test that aims to save lives by diagnosing ...mercia.co....
08.03.2023CanSense Raises £1.5M in FundingCanSense, a Swansea, UK-based developer of blood test to detect early-stage bowel cancer, raised £1....finsmes.co...
-CanSense“CanSense – Innovation in cancer diagnostics”fastfounde...

Reviews 0

Sign up to leave a review

Sign up Log In